SCHEMBL17548904

SCHEMBL17548904

COCC(=O)OC(C)C(=O)C(C)C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL804701 0.80 TSHR (0.33) HPGDSMN1; SMN2
SCHEMBL15095099 0.80 MMP1 (0.36) HPGDSMN1; SMN2
SCHEMBL17548902 0.77 KLK7 (0.33)
SCHEMBL26948072 0.77 TSHR (0.36)
SCHEMBL271918 0.77
SCHEMBL18651065 0.75 HPGD (0.32) HPGDSMN1; SMN2
SCHEMBL9888822 0.75 MGAM (0.38) HPGD
SCHEMBL15084386 0.74
SCHEMBL16640289 0.74 NAAA (0.31)
SCHEMBL6578599 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160058698-A1 COMPOSITION FOR CONTROLLED DELIVERY OF BIOACTIVE AGENTS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160058698-A1 COMPOSITION FOR CONTROLLED DELIVERY OF BIOACTIVE AGENTS PGF, IGFBP2, IGFBP6 HPGD 395/4885SMN1; SMN2 1052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.